Answers are grounded in this paper and cite their sources.
Investigation uncovers interactions between graphene quantum dots and serum albumin, suggesting new design approaches for delivery systems.
This study investigates the interaction mechanisms between human serum albumin (HSA) and two structurally distinct ligands S-allyl-cysteine (SAC) and S, N-co-doped graphene quantum dots functionalized by S-allyl-cysteine (DGQD/SAC) using multispectroscopic and computational approaches. Steady-state and time-resolved fluorescence measurements revealed distinct quenching mechanisms: SAC exhibited static quenching through ground-state complex formation (KSV = 2 × 10⁻⁴ ppm¹ at 298 K) with preserved HSA conformation (Δα-helix < 10%), while DGQD/SAC showed dynamic-dominated quenching (KSV = 0.2648 ppm⁻¹ at 298 K and Kq = 26.48 × 10⁶ ppm⁻¹s⁻¹) accompanied by partial protein unfolding (15% α-helix reduction). Förster resonance energy transfer (FRET) analysis confirmed donor-acceptor distances of 2.85 nm for HSA-DGQD/SAC, within optimal range for energy transfer (0.5R₀< r < 1.5R₀). Circular dichroism (CD) spectra demonstrated SAC's localized binding at Sudlow's site I, whereas N, S-GQD/SAC induced tertiary structure perturbations. Thermodynamic profiling revealed entropy-driven binding for both ligands (ΔS > 0), with SAC showing temperature-enhanced affinity (Ka increased from 1.2474 to 1.9902 ppm⁻¹, 298-318 K). These findings provide critical insights for designing HSA-based delivery systems, highlighting SAC's structural preservation advantages and DGQD/SAC's tunable interfacial interactions.
No takes yet. Share an insight, caveat, or question.
Mohammadnejad et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: